Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
American Journal of Physiology. Renal Physiology|January 27, 2017
Diabetes, hypertension, and chronic kidney disease progression: role of DPP4Ravi Nistala, Virginia SavinHemodialysis International. International Symposium on Home Hemodialysis|September 30, 2005
Phosphorus-enriched hemodialysis during pregnancy: Two case reportsSyed Hussain, Virginia Savin, Walter Piering, et al.BMC Nephrology|February 12, 2011
Novel therapies for resistant focal segmental glomerulosclerosis (FONT) phase II clinical trial: study designHoward Trachtman, Suzanne Vento, Debbie Gipson, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 14, 2018
Cardiotrophin-like Cytokine Increases Macrophage-Foam Cell TransitionSarah Pasquin, Véronique Laplante, Shiriane Kouadri, et al.BMC Nephrology|February 2, 2010
Follow-up of phase I trial of adalimumab and rosiglitazone in FSGS: III. Report of the FONT study groupAlexandra Peyser, Nathaniel Machardy, Freya Tarapore, et al.Scientific Reports|March 7, 2018
Effect of human very low-density lipoproteins on cardiotrophin-like cytokine factor 1 (CLCF1) activitySarah Pasquin, Salma Chehboun, Agnieszka Dejda, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 26, 2009
Phase 1 trial of adalimumab in Focal Segmental Glomerulosclerosis (FSGS): II. Report of the FONT (Novel Therapies for Resistant FSGS) study groupMelanie S Joy, Debbie S Gipson, Leslie Powell, et al.Pageof 1